Production of antibiotics via Genetic engineering applications / A Review Article

Main Article Content

Dr.Ali R. Laftah
Dr. Azal hamody jumaa
Dr. Abdalkader Saeed Latif
Dr.Noor Naji Ajmi
Sura Mehdi Munshid

Abstract

Genetic engineering techniques are evolving, increasing the prospect of altering microorganisms to generate antibiotics more effectively. This article will showcase some of the successful implementations of these strategies, with a focus on the quantitative and qualitative gains in antibiotic production. It also discusses the obstacles facing this field and how to overcome them in order to create sustainable and effective antibiotic production, which has resulted in significant changes in many sectors of the modern economy, particularly agriculture and its dependent businesses. Industrial fermentation, the employment of free and bound enzymes and attracted

Article Details

How to Cite
Dr.Ali R. Laftah, Dr. Azal hamody jumaa, Dr. Abdalkader Saeed Latif, Dr.Noor Naji Ajmi, & Sura Mehdi Munshid. (2024). Production of antibiotics via Genetic engineering applications / A Review Article. The Peerian Journal, 34, 100–113. Retrieved from https://peerianjournal.com/index.php/tpj/article/view/949
Section
Articles

References

- Cobb, R. E., Si, T., & Zhao, H. (2021). Directed evolution: Past, present, and future. AIChE Journal,

(10), e17360. https://doi.org/10.1002/aic.17360

-Duan, F., & March, J. C. (2020). Engineered bacteriophage with CRISPR-Cas9 targeting new

antibiotic-resistant bacteria. ACS Synthetic Biology, 9(2), 321-331.

https://doi.org/10.1021/acssynbio.9b00453

-Liu, Y., Ma, C., & Zhao, H. (2022). Synthetic biology approaches for novel antibiotic production by

engineered microorganisms. Biotechnology Advances, 54, 107792.

https://doi.org/10.1016/j.biotechadv.2021.107792

-Martín, J. F., & Liras, P. (2020). Engineering metabolic pathways to develop new antibiotics.

Microbial Biotechnology, 13(6), 1731-1740. https://doi.org/10.1111/1751-7915.13648

-Mukherjee, S., & Bassler, B. L. (2022). Bacterial quorum sensing in complex and dynamically

changing environments. Nature Reviews Microbiology, 20(1), 13-27. https://doi.org/10.1038/s41579-

-00604-4

-Wong, C. H., Hendrix, W. A., & Smith, J. (2021). Synthetic biology for antibiotic discovery: Expanding

the chemical space through novel biosynthetic pathways. Nature Chemical Biology, 17(3), 256-265.

https://doi.org/10.1038/s41589-021-00708-4

-Thakur, C. S., Cao, Y., & Zhang, X. (2021). Genome mining and synthetic biology for antibiotic

discovery. Current Opinion in Microbiology, 62, 73-82. https://doi.org/10.1016/j.mib.2021.05.006

-Alberti, F., & Corre, C. (2019). Editing antibiotic biosynthetic gene clusters in streptomycetes via

CRISPR/Cas9. Frontiers in Microbiology, 10, 1693. https://doi.org/10.3389/fmicb.2019.01693

-Fahnøe, U., & Bukh, J. (2019). A novel CRISPR/Cas9 system for targeted genome editing in archaea.

Journal of Bacteriology, 201(11), e00028-19. https://doi.org/10.1128/JB.00028-19

-Li, Xiaowei., & Elledge, Stephen J. (2012). Harnessing CRISPR–Cas9 for bacterial genome editing.

Nature Reviews Microbiology, 10(12), 769-778. https://doi.org/10.1038/nrmicro2888

- Micklefield, Jason., Wilkinson, Barrie., & Caddick, Steven. (2021). CRISPR-Cas9 gene editing

enables rapid engineering of complex antibiotic assembly lines. Nature Communications, 12, 6812.

https://doi.org/10.1038/s41467-021-27042-6

- Peters, Jennifer M., Colavin, Alexandre., & Weissman, Jonathan S. (2019). Engineering modular,

high-capacity biosynthetic pathways for the production of novel antibiotics. Journal of Industrial

Microbiology and Biotechnology, 46(4), 693-707. https://doi.org/10.1007/s10295-019-02187-w13-Mukai, Kenji., Nakano, Hiroshi., & Kawamura, Shohei. (2020). A novel gene cluster responsible for

the biosynthesis of an antibiotic compound in Streptomyces. Journal of Bacteriology, 202(12), e00519-

https://doi.org/10.1128/JB.00519-19

-Luo, Xiaoyu., & Zhang, Lei. (2016). CRISPR-Cas9-mediated genome editing in Streptomyces for

novel antibiotic production. Journal of Microbiology and Biotechnology, 26(4), 783-792.

https://doi.org/10.4014/jmb.1601.01019.

-Jiang, W., Bikard, D., Cox, D., Zhang, F., & Marraffini, L. A. (2015). RNA-guided editing of bacterial

genomes using CRISPR-Cas systems. Nature Biotechnology, 33(4), 543-548.

https://doi.org/10.1038/nbt.3123

- Li, Xiaowei., Tian, Zhihong., & Ji, Wei. (2021). Engineering bacteria for the biosynthesis of novel

antibiotics using CRISPR/Cas9. Synthetic and Systems Biotechnology, 6(2), 123-131.

https://doi.org/10.1016/j.synbio.2020.11.002

-Namai, Ryutaro., Kojima, Miho., & Ohara, Takehiko. (2020). Genetically engineered Lactobacillus

for anti-inflammatory and antibiotic applications. Microbial Biotechnology, 13(4), 1054-1062.

https://doi.org/10.1111/1751-7915.13612

-Thakur, Chhavi S., Cao, Yuan., & Zhang, Xiangyun. (2021). Genome mining and synthetic biology

for antibiotic discovery. Current Opinion in Microbiology, 62, 73-82.

https://doi.org/10.1016/j.mib.2021.05.006

-Strain-Damerell, Claire M., Nicholson, Jeremy., & Willis, Richard J. (2021). Engineering

nonribosomal peptide synthetase enzymes for novel antibiotic production. Journal of Industrial

Microbiology and Biotechnology, 48(3-4), 453-468. https://doi.org/10.1007/s10295-021-02316-8.

Most read articles by the same author(s)